At the NanoBioMedical Centre we design, characterize and functionalize large variety of NANOMATERIALS of different dimensions (OD, 1D, 2D and 3D) including:

• metallic nanoparticles: Au, Ag, Cu;
• metal oxides: ZnO, TiO₂, CuO, Cu₂O, Fe₂O₃, Fe₃O₄, Gd₂O₃;
• phosphates:  hydroxyapatite and its derivatives;
• quantum dots: Cu₂O, CuInS/ZnS, GQDs, CQDs;
• carbon nanomaterials: nanotubes, graphene, graphene oxide;
• organic: cubosomes, liposomes, micelles, peptides, polydopamine spheres, dendrimers;
• thin films: Heusler’s alloys, carbides, nitrides, iron oxide layers, TiO₂, ZnO;
• hybrid, hierarchical and porous: polydopamine coated magnetic Fe₃O₄ nanoparticles, MOFs,  MSNs, ZnO.

These nanomaterials are further given to the functionalization in order to ensure novel properties. To do so, we:

• change the stability and improve the functionality of nanomaterials by tuning the hydrophobicity and surface charge,
• combine the nanomaterials of different properties to form multimodal particles with many functions: such as fluorescence and magnetic imaging probes that can selectively deliver drug molecules,
• develop new hybrid materials, built from at least two functional components, with new unique physicochemical and biological properties.

Presentation of chosen materials obtained in the NBMC: